At1g23250 Antibody

What is AT1G23250 and why is it significant in plant research?

AT1G23250 encodes a caleosin-related family protein in Arabidopsis thaliana, also known as CLO7 . It belongs to the caleosin family, which consists of calcium-binding proteins primarily associated with lipid droplets (LDs) and the endoplasmic reticulum in plants . Caleosins are significant in plant research because they play crucial roles in lipid metabolism, particularly during seed germination and seedling development. Research on caleosins, including CLO7, contributes to our understanding of lipid storage mobilization mechanisms, which has implications for crop improvement and biofuel production. Related caleosins like CLO1 have been shown to interact with autophagy machinery components such as ATG8, suggesting roles in lipid droplet degradation through microlipophagy .

How can researchers detect AT1G23250/CLO7 protein in plant tissues?

Based on approaches used for related caleosins, researchers can detect AT1G23250/CLO7 protein using:

• Immunoblotting (Western blot) with specific anti-CLO7 antibodies, similar to the detection method used for CLO1

• Immunolocalization in tissue sections

• GFP/YFP fusion proteins for live-cell imaging and subcellular localization studies

• Co-immunoprecipitation experiments to identify protein interactions

For immunoblotting, researchers typically extract total proteins from plant tissues, separate them by SDS-PAGE, transfer to membranes, and probe with specific anti-caleosin antibodies. For example, with the related CLO1 protein, researchers detected a single protein band of approximately 26 kDa in seed extracts, with highest levels observed in mature seeds and progressively decreasing levels during germination .

What are the recommended tissue samples for AT1G23250/CLO7 detection?

Based on expression patterns of related caleosins:

Researchers should consider that expression levels may vary significantly throughout development, particularly during germination when lipid reserves are mobilized .

What are the key considerations when generating antibodies against AT1G23250/CLO7?

When developing antibodies against AT1G23250/CLO7:

• Epitope selection: Choose unique regions that differ from other caleosin family members to ensure specificity. Avoid highly conserved regions like the calcium-binding EF-hand domain unless family-wide detection is desired.

• Protein structure analysis: Consider that caleosins contain:

  • N-terminal calcium-binding domain

  • Central hydrophobic domain (proline knot)

  • C-terminal region that may contain AIMs (ATG8-interacting motifs)

• Validation controls: Include appropriate positive controls (tissues with known expression) and negative controls (knockout mutants if available). For the related CLO1, researchers confirmed antibody specificity by detecting protein in wild-type and clo2 mutants but not in clo1 and clo1 clo2 double mutants .

• Cross-reactivity testing: Test against other caleosin family members to ensure specificity for CLO7.

How can researchers validate the specificity of AT1G23250/CLO7 antibodies?

To validate antibody specificity:

• Genetic approach: Test antibody reactivity in wild-type plants versus clo7 knockout/knockdown mutants. The antibody should detect the protein in wild-type but show reduced or no signal in mutants.

• Protein analysis: Perform Western blots with recombinant CLO7 protein and total protein extracts from tissues expressing CLO7.

• Immunoprecipitation-Mass Spectrometry: Perform immunoprecipitation followed by mass spectrometry to confirm that the antibody captures the intended protein.

• Heterologous expression: Express tagged versions of CLO7 in systems like E. coli or yeast and confirm antibody detection.

Similar approaches were used for CLO1, where antibody specificity was confirmed by comparing protein detection in wild-type and various caleosin mutant backgrounds .

What is the recommended protocol for immunoblotting AT1G23250/CLO7?

Based on successful protocols with related caleosins:

• Protein extraction:

  • Grind tissue in liquid nitrogen

  • Extract with buffer containing detergent (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, protease inhibitors)

  • For lipid droplet-associated proteins, consider specialized extraction methods

• SDS-PAGE and transfer:

  • Separate 10-20 μg protein on 12-15% acrylamide gels

  • Transfer to PVDF or nitrocellulose membrane

• Immunodetection:

  • Block with 5% non-fat milk or BSA

  • Incubate with primary anti-CLO7 antibody (1:1000-1:5000 dilution)

  • Wash and incubate with HRP-conjugated secondary antibody

  • Detect using enhanced chemiluminescence

• Controls:

  • Include positive control (tissue with known CLO7 expression)

  • Include negative control (clo7 mutant if available)

  • Use loading control antibody (e.g., anti-actin)

For the related CLO1 protein, researchers successfully detected a single band of approximately 26 kDa in seed extracts .

How can AT1G23250/CLO7 antibodies be used to study protein-protein interactions?

Researchers can employ several approaches:

• Co-immunoprecipitation (Co-IP):

  • Prepare protein extracts from tissues expressing CLO7

  • Immunoprecipitate using anti-CLO7 antibody

  • Analyze co-precipitated proteins by immunoblotting or mass spectrometry

  For CLO1, researchers successfully used co-immunoprecipitation with anti-CLO1 antibody to demonstrate interaction with ATG8 in lipid droplet protein extracts from imbibed seeds .

• Yeast two-hybrid confirmations:

  • Based on identified interactions

  • Similar to the approach used to confirm CLO1-ATG8 interactions

• Proximity-dependent labeling:

  • Fusion of CLO7 with enzymes like BioID or APEX2

  • Biotinylation of proximal proteins

  • Verification of interactions using antibodies

What controls should be included when using AT1G23250/CLO7 antibodies in research?

For rigorous experimental design, include:

• Genetic controls:

  • Wild-type tissues (positive control)

  • clo7 knockout/knockdown mutants (negative control)

  • Other caleosin mutants to assess cross-reactivity

• Technical controls:

  • Secondary antibody-only controls

  • Pre-immune serum controls

  • Peptide competition assays (incubating antibody with excess antigen peptide)

• Loading and normalization controls:

  • Housekeeping proteins (actin, tubulin, GAPDH)

  • Total protein staining (Ponceau S, Coomassie)

• Positive controls from published studies:

  • Include samples/conditions known to express CLO7

  • Compare detection patterns with published data on related caleosins

How can AT1G23250/CLO7 antibodies be used to study lipid droplet dynamics?

AT1G23250/CLO7 antibodies can provide valuable insights into lipid droplet biology:

• Subcellular fractionation and immunoblotting:

  • Isolate lipid droplet fractions from tissues

  • Perform Western blotting to detect CLO7 in different fractions

  • Compare with other subcellular markers

  For CLO1, researchers isolated lipid droplet fractions from germinating seeds and confirmed CLO1 presence using specific antibodies, demonstrating its association with lipid bodies .

• Co-localization studies:

  • Use fluorescently-labeled anti-CLO7 antibodies in immunofluorescence

  • Counter-stain with lipid droplet dyes (BODIPY, Nile Red)

  • Analyze using confocal microscopy

• Time-course analysis:

  • Monitor CLO7 levels during developmental processes

  • Correlate with lipid droplet degradation rates

  • Similar to CLO1 studies showing progressive decrease during germination

How do mutations in ATG8-interacting motifs (AIMs) affect antibody recognition of AT1G23250/CLO7?

Based on studies with related caleosins:

• Epitope considerations:

  • If the antibody epitope overlaps with AIMs, recognition could be affected

  • AIM mutations may cause conformational changes affecting distant epitopes

• Research approaches:

  • Generate AIM mutant versions (e.g., by deleting or mutating critical residues)

  • Compare antibody recognition between wild-type and mutant proteins

  • Perform parallel functional analyses to correlate antibody binding with protein function

In CLO1, researchers identified and mutated two AIMs (AIM1: aa 112-117 and AIM2: aa 196-202) that significantly affected interaction with ATG8b . If antibodies recognize regions containing these motifs, binding could be affected by similar mutations in CLO7.

What methodological approaches can resolve contradictory findings when using AT1G23250/CLO7 antibodies?

When researchers encounter contradictory results:

• Antibody validation:

  • Re-validate antibody specificity using multiple approaches

  • Test different antibody lots or sources

  • Consider epitope-specific versus polyclonal antibodies

• Technical troubleshooting:

  • Optimize protein extraction conditions (detergents, buffers)

  • Test different blocking agents to reduce background

  • Adjust antibody concentrations and incubation times

• Biological variability assessment:

  • Control for developmental stages precisely

  • Consider tissue-specific expression patterns

  • Evaluate effects of environmental conditions on CLO7 expression

• Orthogonal approaches:

  • Complement antibody studies with GFP-fusion protein localization

  • Use RNA analysis (qRT-PCR, RNA-Seq) to correlate with protein detection

  • Similar to the approach in CLO1 studies where protein detection was correlated with qRT-PCR analysis

How can researchers distinguish between AT1G23250/CLO7 and other caleosin family members using antibodies?

Distinguishing between closely related caleosins requires:

• Epitope selection strategies:

  • Generate antibodies against unique regions with low sequence conservation

  • Target caleosin-specific regions rather than common functional domains

  • Consider C-terminal regions that often diverge between family members

• Cross-reactivity testing:

  • Test antibody against recombinant proteins of all caleosin family members

  • Perform immunoblotting on tissues from single and multiple caleosin mutants

  • Similar to CLO1 antibody testing in clo1, clo2, and clo1 clo2 genetic backgrounds

• Band pattern analysis:

  Caleosin	Molecular Weight	Expression Pattern	Notes
  CLO1	~26 kDa	High in seeds, decreasing during germination	Associated with seed LDs
  CLO7	Predicted size	Variable	Tissue-specific patterns may differ

How do antibody-based detection methods for AT1G23250/CLO7 compare with other protein detection techniques?

Comparison of detection methods:

• Antibody-based detection:

  • Advantages: Direct protein detection, quantifiable, can detect native protein

  • Limitations: Specificity concerns, requires validation, may not detect all isoforms

  • Best applications: Protein quantification, localization studies, co-immunoprecipitation

• Fluorescent protein fusions:

  • Advantages: Live imaging, real-time dynamics, no fixation artifacts

  • Limitations: May affect protein function, overexpression concerns

  • Best applications: Subcellular localization, protein dynamics

• Mass spectrometry:

  • Advantages: High specificity, can identify post-translational modifications

  • Limitations: Complex sample preparation, expensive equipment

  • Best applications: Proteome-wide studies, modification analysis

• Transcript analysis (qRT-PCR, RNA-Seq):

  • Advantages: Sensitive, can detect low abundance genes

  • Limitations: mRNA levels may not correlate with protein levels

  • Best applications: Expression profiling, detecting splice variants

  Researchers studying MS1 successfully used qRT-PCR with β-tubulin as internal control , an approach that could complement protein studies of CLO7.

What are the optimal conditions for studying AT1G23250/CLO7 interactions with autophagy machinery?

Based on studies of related caleosins:

• Developmental timing:

  • Focus on germination stages when lipid mobilization is active

  • For CLO1 and ATG8, protein interaction was detected during seed germination and correlated with lipid droplet degradation

• Experimental conditions:

  • Test both standard light conditions and stress conditions (e.g., darkness)

  • CLO1-ATG8 co-localization was observed under both long day and continuous dark conditions

• Subcellular fractionation approach:

  • Isolate lipid droplet fractions to enrich for caleosin-ATG8 interactions

  • In CLO1 studies, ATG8-PE was predominantly found associated with lipid droplet fractions

• Detection methods:

  • Co-immunoprecipitation with anti-CLO7 antibodies followed by immunoblotting for ATG8

  • Reciprocal co-IP with anti-ATG8 antibodies

  • Fluorescence microscopy to detect co-localization

How should researchers interpret changes in AT1G23250/CLO7 antibody signals during plant development and stress responses?

For accurate interpretation:

• Quantitative analysis framework:

  • Normalize antibody signals to loading controls

  • Consider total protein normalization (Ponceau S, Coomassie staining)

  • Use biological and technical replicates (minimum three of each)

  • Perform statistical analysis of signal intensity changes

• Developmental context:

  • For seed germination, establish a clear time course (e.g., dry seeds, 24h, 48h, 72h post-imbibition)

  • CLO1 showed progressive decrease during germination, correlating with lipid droplet degradation

• Stress response interpretation:

  • Compare unstressed controls with stress treatments

  • Consider tissue-specific responses

  • Correlate protein changes with physiological responses

• Validation by orthogonal methods:

  • Confirm protein level changes with transcript analysis

  • Use GFP-fusion proteins to validate localization changes

  • Consider proteomics approaches for global protein changes

What are the most common causes of non-specific binding when using AT1G23250/CLO7 antibodies and how can they be addressed?

Common issues and solutions:

• Cross-reactivity with related proteins:

  • Solution: Pre-absorb antibody with recombinant proteins of related caleosins

  • Validate using knockout mutants as negative controls

  • Consider using peptide competition assays

• High background in immunoblots:

  • Solutions: Increase blocking time/concentration

  • Use alternative blocking agents (BSA, commercial blockers instead of milk)

  • Increase washing stringency (more washes, higher detergent concentration)

  • Optimize antibody dilution (typically test range from 1:500 to 1:5000)

• Multiple bands in Western blots:

  • Solutions: Optimize extraction conditions to prevent degradation

  • Add additional protease inhibitors

  • Consider native vs. denaturing conditions

  • Verify if bands represent isoforms, post-translational modifications, or degradation products

• Low signal-to-noise ratio:

  • Solutions: Enrich target protein by subcellular fractionation

  • Increase protein loading while maintaining linearity

  • Use more sensitive detection systems (enhanced chemiluminescence)

How can researchers optimize immunoprecipitation protocols for AT1G23250/CLO7 to study protein interactions?

For successful co-immunoprecipitation studies:

• Buffer optimization:

  • Test different lysis buffers with varying salt and detergent concentrations

  • For membrane-associated proteins like caleosins, include appropriate detergents

  • Consider crosslinking to stabilize transient interactions

• Antibody coupling:

  • Covalently couple antibodies to beads to prevent co-elution

  • Compare protein A/G beads with direct coupling methods

  • Determine optimal antibody-to-bead ratio

• Controls and validation:

  • Include IgG control immunoprecipitations

  • Perform reciprocal co-IPs (e.g., IP with anti-CLO7 and anti-ATG8)

  • Validate interactions by alternative methods (Y2H, BiFC)

  For CLO1, researchers successfully used co-immunoprecipitation with anti-CLO1 antibody to demonstrate interaction with ATG8 .

• Elution conditions:

  • Compare harsh (reducing, denaturing) vs. mild (peptide competition) elution

  • Consider native elution for downstream functional assays

  • Optimize elution volume to concentrate proteins for detection

How might AT1G23250/CLO7 antibodies contribute to understanding evolutionary conservation of lipid metabolism across plant species?

Future comparative research opportunities:

• Cross-species antibody applications:

  • Test anti-Arabidopsis CLO7 antibodies on proteins from crop species

  • Identify conserved epitopes for pan-species antibody development

  • Use antibodies to compare caleosin expression patterns across diverse plants

• Evolutionary studies:

  • Compare caleosin protein levels and subcellular localization across plant lineages

  • Correlate with differences in lipid storage strategies

  • Investigate functional conservation through complementation studies

• Structure-function analysis:

  • Use antibodies to assess the conservation of protein-protein interactions

  • Compare post-translational modifications across species

  • Investigate whether ATG8-interacting motifs (AIMs) identified in Arabidopsis caleosins are functionally conserved in other plants

What methodological advances might improve AT1G23250/CLO7 antibody applications in plant research?

Emerging technologies and approaches:

• Single-cell protein analysis:

  • Adaptation of antibody-based techniques for single-cell proteomics

  • Integration with single-cell transcriptomics data

  • Development of high-sensitivity detection methods

• Microfluidic applications:

  • Miniaturized immunoassays requiring less antibody and sample

  • High-throughput antibody screening platforms

  • Integration with live imaging systems

• Nanobody development:

  • Generation of single-domain antibodies with improved tissue penetration

  • Engineering for direct fluorophore conjugation

  • Application in super-resolution microscopy

• Spatially resolved proteomics:

  • Coupling antibody-based detection with spatial transcriptomics

  • Development of multiplexed immunolabeling approaches

  • Integration with mass spectrometry imaging